Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001607062-22-000470
Filing Date
2022-07-22
Accepted
2022-07-22 12:01:38
Documents
48
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-K sybleu063022form10k.htm   iXBRL 10-K 779866
7 EXHIBIT 31.1 ex31_1.htm EX-31.1 14973
8 EXHIBIT 31.2 ex31_2.htm EX-31.2 13651
9 EXHIBIT 32.1 ex32_1.htm EX-32.1 3150
10 EXHIBIT 32.2 ex32_2.htm EX-32.2 3474
  Complete submission text file 0001607062-22-000470.txt   2991334

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE cik0001818674-20220630.xsd EX-101.SCH 21791
3 XBRL CALCULATION FILE cik0001818674-20220630_cal.xml EX-101.CAL 37355
4 XBRL DEFINITION FILE cik0001818674-20220630_def.xml EX-101.DEF 45966
5 XBRL LABEL FILE cik0001818674-20220630_lab.xml EX-101.LAB 161301
6 XBRL PRESENTATION FILE cik0001818674-20220630_pre.xml EX-101.PRE 131083
42 EXTRACTED XBRL INSTANCE DOCUMENT sybleu063022form10k_htm.xml XML 385203
Mailing Address 109 EAST 17TH STREET SUITE 460 CHEYENNE WY 82001
Business Address 109 EAST 17TH STREET SUITE 460 CHEYENNE WY 82001 6192279192
SYBLEU Inc (Filer) CIK: 0001818674 (see all company filings)

EIN.: 851412307 | State of Incorp.: WY | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 333-248059 | Film No.: 221099186
SIC: 2834 Pharmaceutical Preparations